Q119Y_human-BCHE

General

Gene Locus : human-BCHE

Mode of mutation : Site directed mutagenesis

Disease :

Summary : Peripheral Anionic Site vKi BW284C51 Loewenstein-Lichtenstein_1996_Mol.Pharmacol_50_1423 || Peripheral Anionic Site no role in substrate binding Masson_1995_5th.ChE.Meeting.Madras__230

AAA Change :

Allelic Variant :

Risk Factor :

Inhibitor :

Structure :

Disease by interaction :

Interact Gene Locus :

Xenobiotic sensitivity :

Modification : Peripheral Anionic Site

Torpedo_number : 121

Kinetic Parameter : Butyrylthiocholine_Q119Y_human-BCHE, Tacrine_Q119Y_human-BCHE, Succinylcholine~Suxamethonium_Q119Y_human-BCHE, Dibucaine_Q119Y_human-BCHE, Solanine_Q119Y_human-BCHE, BW284C51_Q119Y_human-BCHE

News : No news

Comment :
p.Q119Y Gln119Tyr (p.Q147Y Gln147Tyr in primary sequence with 28 amino-acids signal peptide) Peripheral Anionic Site, no role in substrate binding

References (3)

Title : Asp7O in the peripheral anionic site of human butyrylcholinesterase - Masson_1996_Eur.J.Biochem_235_36
Author(s) : Masson P , Froment MT , Bartels CF , Lockridge O
Ref : European Journal of Biochemistry , 235 :36 , 1996
Abstract :
PubMedSearch : Masson_1996_Eur.J.Biochem_235_36
PubMedID: 8631355

Title : Overlapping drug interaction sites of human butyrylcholinesterase dissected by site-directed mutagenesis - Loewenstein-Lichtenstein_1996_Mol.Pharmacol_50_1423
Author(s) : Loewenstein-Lichtenstein Y , Glick D , Gluzman N , Sternfeld M , Zakut H , Soreq H
Ref : Molecular Pharmacology , 50 :1423 , 1996
Abstract :
PubMedSearch : Loewenstein-Lichtenstein_1996_Mol.Pharmacol_50_1423
PubMedID: 8967962
Gene_locus related to this paper: human-BCHE

Title : Peripheral Anionic Site of Wild-Type and Mutant Human Butyrylcholinesterase -
Author(s) : Masson P , Froment MT , Bartels CF , Lockridge O
Ref : In Enzyme of the Cholinesterase Family - Proceedings of Fifth International Meeting on Cholinesterases , (Quinn, D.M., Balasubramanian, A.S., Doctor, B.P., Taylor, P., Eds) Plenum Publishing Corp. :230 , 1995
PubMedID: